On behalf of FDA Commissioner Marty Makary, M.D., M.P.H., the FDA is holding a series of roundtable discussions with independent panels of scientific experts that will review the latest scientific evidence, evaluate potential health risks, explore safer alternatives, and may offer recommendations for regulatory action. This initiative is part of the FDA’s broader efforts to apply| RxISK - Making Medicines Safer for All of Us
Epidemiology deals in correlations that are subject to confounding. Think tobacco and lung cancer. Although studies should attempt to account for confounding, confounding can also be exploited to explain away inconvenient data as tobacco company claims that correlations do not prove causation illustrated. This underpinned the famous Doubt is our Product tobacco company strategy, which| RxISK - Making Medicines Safer for All of Us